Parkman Healthcare Partners LLC Increases Position in UnitedHealth Group Incorporated $UNH

Parkman Healthcare Partners LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 151.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 50,213 shares of the healthcare conglomerate’s stock after purchasing an additional 30,213 shares during the period. UnitedHealth Group accounts for 3.1% of Parkman Healthcare Partners LLC’s portfolio, making the stock its 8th largest position. Parkman Healthcare Partners LLC’s holdings in UnitedHealth Group were worth $26,299,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Bayforest Capital Ltd increased its position in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd increased its position in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 50 shares during the period. Copia Wealth Management acquired a new stake in UnitedHealth Group in the 4th quarter valued at approximately $42,000. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter valued at $42,000. Finally, Investment Management Corp VA ADV acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at $44,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $315.10 on Friday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $285.38 billion, a price-to-earnings ratio of 13.65, a P/E/G ratio of 2.00 and a beta of 0.45. The stock’s fifty day simple moving average is $288.78 and its 200-day simple moving average is $374.41.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the prior year, the firm posted $6.80 EPS. The business’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.28% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

UNH has been the topic of several research analyst reports. Piper Sandler lowered their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. Mizuho lowered their price target on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research report on Friday, May 16th. Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. Wolfe Research cut their price objective on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research report on Tuesday, May 20th. Finally, UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $354.86.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.